Programa de Nanomedicinas, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Roque Saenz Peña 352, Bernal, B1876 BXD, Buenos Aires, Argentina.
Nanomedicine. 2012 Nov;8(8):1319-28. doi: 10.1016/j.nano.2012.02.008. Epub 2012 Feb 24.
UNLABELLED: Ultradeformable archaeosomes (UDA) are vesicles made of soybean phosphatidylcholine (SPC), sodium cholate (NaChol) and polar lipids from Halorubrum tebenquichense (3:1:3 wt/wt). Although ultradeformable liposomes (UDL, made of SPC and NaChol at 6:1 wt/wt) and UDA were neither captured nor caused cytotoxicity on keratinocytes, UDA was avidly captured by macrophages, their viability being reduced by 0.4-1.6 mg/mL phospholipids by 25 to 60%. Instead, UDL were poorly captured and caused no toxicity. Balb/C mice immunized by the topical route with four doses of ovalbumin (OVA)-loaded UDA, at 75 μg OVA/600 μg phospholipids (125 nm mean size and -42 mV zeta potential), induced IgG titers tenfold to 100-fold higher than those immunized with OVA-loaded UDL at the same dosage. Both matrices penetrate to the same skin depth (nearly 10 μm after 1 hour on excised human skin), being the higher topical adjuvancy and higher phagocytic uptake of UDA related to its glycolipid content. FROM THE CLINICAL EDITOR: This work summarizes key findings related to the development of ultradeformable archaeosomes as vehicles utilized in transdermal delivery systems with improved skin penetration.
未加标签:超变形 archaeosomes(UDA)是由大豆卵磷脂(SPC)、胆酸钠(NaChol)和来自 Halorubrum tebenquichense 的极性脂质(3:1:3wt/wt)制成的囊泡。尽管超变形脂质体(UDL,由 SPC 和 NaChol 以 6:1wt/wt 制成)和 UDA 既不会被角质形成细胞捕获也不会引起细胞毒性,但 UDA 被巨噬细胞大量捕获,其活力在 0.4-1.6mg/ml 磷脂存在时降低 25%至 60%。相反,UDL 则很少被捕获且不会引起毒性。用四种剂量的卵清蛋白(OVA)负载 UDA(75μgOVA/600μg 磷脂(平均大小为 125nm,ζ 电位为-42mV))通过经皮途径对 Balb/C 小鼠进行免疫,可诱导 IgG 滴度比相同剂量的 OVA 负载 UDL 高 10 至 100 倍。两种基质都渗透到相同的皮肤深度(在离体人皮肤上 1 小时后接近 10μm),UDA 的较高的透皮佐剂和较高的吞噬摄取与其糖脂含量有关。
FROM THE CLINICAL EDITOR:这项工作总结了与超变形 archaeosomes 作为经皮给药系统中改善皮肤渗透的载体的开发相关的关键发现。
Nanomedicine. 2012-2-24
Colloids Surf B Biointerfaces. 2014-9-1
Drug Dev Ind Pharm. 2022-11
BMC Biotechnol. 2009-8-13
Colloids Surf B Biointerfaces. 2017-4-1
Colloids Surf B Biointerfaces. 2018-11-15
J Control Release. 2004-3-24
Hum Vaccin Immunother. 2024-12-31
Beilstein J Nanotechnol. 2024-5-13
Beni Suef Univ J Basic Appl Sci. 2022
Pharmaceutics. 2022-3-29
Pharmaceutics. 2021-8-25
Expert Rev Vaccines. 2021-5
Front Bioeng Biotechnol. 2018-11-6
Hum Vaccin Immunother. 2017-5-24